Pacific Biosciences of California PACB Product revenue — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's product revenue — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's product revenue — total revenue?
- Pacific Biosciences of California (PACB) reported product revenue — total revenue of $31.53M in Q1 2026.
- How has Pacific Biosciences of California's product revenue — total revenue changed year-over-year?
- Pacific Biosciences of California's product revenue — total revenue increased by 1.4% year-over-year, from $31.11M to $31.53M.
- What does product revenue — total revenue mean?
- This metric represents the total gross revenue generated specifically from the sale of physical products, such as sequencing instruments and consumables, within the company's genetic analysis platform. It serves as a primary indicator of market adoption and the commercial scale of the company's core hardware and reagent offerings. Tracking this figure helps investors assess the company's ability to monetize its proprietary technology and grow its installed base of sequencing systems.